<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: INCY News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=incy</link><description>Latest Financial News for Incyte Corporation</description><language>en-us</language><lastBuildDate>Sat, 12 Dec 2009 13:00:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Data from a Phase I/II Study Presented at the 32nd San Antonio Breast Cancer Symposium Suggest that INCB7839 in Combination with Trastuzumab May Improve Clinical Response Rates in HER2 Positive Patients with Advanced Metastatic Disease (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091212/20091212005009.html?.v=1</link><description>WILMINGTON, Del.----Incyte Corporation announced today positive results from an ongoing Phase I/II clinical trial for its selective oral sheddase inhibitor, INCB7839, involving 46 patients with HER2 positive metastatic breast cancer.</description><guid isPermaLink="false">yahoo_finance/3625914869</guid><pubDate>Sat, 12 Dec 2009 13:00:00 Etc/GMT</pubDate></item><item><title>Biotechs to Watch in the Blood Business (at Minyanville.com)</title><link>http://us.rd.yahoo.com/finance/external/minyanville/rss/SIG=15477jgt9/*http%3A//www.minyanville.com/articles/American-Society-Hematology-meeting-research-treanda-carfilzomib-INCB424-myeloma-cancer-minyanville/index/a/25786/from/yahoo</link><description>Companies making headlines at an annual hematology conference.</description><guid isPermaLink="false">yahoo_finance/1801430030</guid><pubDate>Mon, 7 Dec 2009 20:20:00 Etc/GMT</pubDate></item><item><title>Data from Three Phase II Trials to be Presented at the 51st American Society of Hematology Annual Meeting Demonstrate that INCB18424, a Selective JAK1/JAK2 Inhibitor, Has Potential in Multiple Hematology Conditions (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091207/20091207005329.html?.v=1</link><description>WILMINGTON, Del.----Incyte Corporation announced this morning that INCB18424 , its selective, orally available janus kinase inhibitor, will be the subject of three oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.</description><guid isPermaLink="false">yahoo_finance/1119384712</guid><pubDate>Mon, 7 Dec 2009 13:00:00 Etc/GMT</pubDate></item><item><title>Incyte to Host Webcast at 51st American Hematology Annual Meeting (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091202/20091202006293.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3228908069</guid><pubDate>Wed, 2 Dec 2009 21:10:00 Etc/GMT</pubDate></item><item><title>Lightning Round OT: Incyte, Randgold Resources and More (at CNBC)</title><link>http://us.rd.yahoo.com/finance/external/cnbc/blog/rss/SIG=11hhupeu4/*http%3A//www.cnbc.com/id/34223943/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&amp;par=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/3669560925</guid><pubDate>Wed, 2 Dec 2009 00:16:07 Etc/GMT</pubDate></item><item><title>4-Star Stocks on the Upswing (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12m34pv19/*http%3A//www.fool.com/investing/general/2009/12/01/4-star-stocks-on-the-upswing.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/3673829416</guid><pubDate>Tue, 1 Dec 2009 20:04:49 Etc/GMT</pubDate></item><item><title>Great Opportunity for Incyte (Zacks.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091130/27733.html?.v=1</link><description>Incyte Corporation has entered into a collaboration and license agreement with Novartis AG regarding the development and potential commercialization of two of its pipeline candidates.</description><guid isPermaLink="false">yahoo_finance/329968766</guid><pubDate>Mon, 30 Nov 2009 15:21:43 Etc/GMT</pubDate></item><item><title>[$$] Charting The Market (at Barrons.com)</title><link>http://us.rd.yahoo.com/finance/external/barrons/rss/SIG=11vmtgsjr/*http%3A//online.barrons.com/article/SB125935443939366899.html?ru=yahoo&amp;mod=yahoobarrons</link><description>Charting The Market A graphic look at selected stock activity for the week ended Nov. 27, 2009.</description><guid isPermaLink="false">yahoo_finance/2359529303</guid><pubDate>Sat, 28 Nov 2009 13:03:54 Etc/GMT</pubDate></item><item><title>A Fool Looks Back (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12b017pts/*http%3A//www.fool.com/investing/general/2009/11/28/a-fool-looks-back.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/3171696621</guid><pubDate>Sat, 28 Nov 2009 13:03:22 Etc/GMT</pubDate></item><item><title>[$$] Tivo Falls 6.8%, While Basic Energy Surges (at The Wall Street Journal Online)</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12ivaq3mp/*http%3A//online.wsj.com/article/SB10001424052748704498804574558201135344522.html?ru=yahoo&amp;mod=yahoo_hs</link><description></description><guid isPermaLink="false">yahoo_finance/3427354409</guid><pubDate>Wed, 25 Nov 2009 22:54:16 Etc/GMT</pubDate></item><item><title>[$$] Stocks in the News: the Good News and the Bad News (at The Wall Street Journal Online)</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12is6dvt2/*http%3A//online.wsj.com/article/SB10001424052748704611404574556441383064228.html?ru=yahoo&amp;mod=yahoo_hs</link><description></description><guid isPermaLink="false">yahoo_finance/4207957688</guid><pubDate>Wed, 25 Nov 2009 22:45:49 Etc/GMT</pubDate></item><item><title>S&amp;P holds 1,100 level ahead of Thanksgiving (at FT.com)</title><link>http://us.rd.yahoo.com/finance/external/ft/rss/SIG=125klhd1g/*http%3A//www.ft.com/cms/s/b480eece-d9d5-11de-ad94-00144feabdc0.html?referrer_id=yahoofinance&amp;ft_ref=yahoo1&amp;segid=03058</link><description>Encouraging results from Tiffany added to the holiday cheer on Wall Street on Wednesday after economic data and the weak dollar lifted stocks to fresh highs for the year.</description><guid isPermaLink="false">yahoo_finance/3659563533</guid><pubDate>Wed, 25 Nov 2009 22:05:34 Etc/GMT</pubDate></item><item><title>[$$] Charting the Market Wednesday (at Barrons.com)</title><link>http://us.rd.yahoo.com/finance/external/barrons/rss/SIG=11v4pk6c9/*http%3A//online.barrons.com/article/SB125910101911662579.html?ru=yahoo&amp;mod=yahoobarrons</link><description>Charting the Market Wednesday Shares of J. Crew, Incyte, Tiffany and JDS Uniphase all rose on Wednesday with the broader market.</description><guid isPermaLink="false">yahoo_finance/1004032369</guid><pubDate>Wed, 25 Nov 2009 21:57:34 Etc/GMT</pubDate></item><item><title>Tiffany, J. Crew, TiVo, Incyte are big movers (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091125/us_wall_street_stocks.html?.v=2</link><description>The following stocks were among those that moved substantially or traded heavily Wednesday on the New York Stock Exchange:</description><guid isPermaLink="false">yahoo_finance/4176556403</guid><pubDate>Wed, 25 Nov 2009 21:25:32 Etc/GMT</pubDate></item><item><title>INCYTE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091125/incy8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2314575761</guid><pubDate>Wed, 25 Nov 2009 21:21:45 Etc/GMT</pubDate></item><item><title>TradingMarkets 7 Stocks You Need to Know for Friday (TradingMarkets.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/tm/091125/51335.html?.v=1</link><description>Stocks closed higher across the board, while U.S. Dollar suffered, hitting 15-month lows against the Euro. Ship Finance International is expecting to see an EPS of 52 cents prior to the bell on Friday.</description><guid isPermaLink="false">yahoo_finance/896420420</guid><pubDate>Wed, 25 Nov 2009 21:09:01 Etc/GMT</pubDate></item><item><title>Incyte Shares Up on Novartis Licensing Deal (at Fox Business)</title><link>http://us.rd.yahoo.com/finance/external/FoxBusiness.com/rss/SIG=12pbrmllf/*http%3A//www.foxbusiness.com/story/markets/industries/health-care/incyte-novartis-deal/</link><description></description><guid isPermaLink="false">yahoo_finance/1766736890</guid><pubDate>Wed, 25 Nov 2009 20:53:10 Etc/GMT</pubDate></item><item><title>Novartis Didn&apos;t Know JAK, Until Now (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12vt3qj4e/*http%3A//www.fool.com/investing/high-growth/2009/11/25/novartis-didnt-know-jak-until-now.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/3896456438</guid><pubDate>Wed, 25 Nov 2009 19:41:30 Etc/GMT</pubDate></item><item><title>Biotech Stocks: Incyte, Idera move on Novartis deals (at MarketWatch)</title><link>http://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12lf0vnc5/*http%3A//www.marketwatch.com/news/story/incyte-idera-move-novartis-deals/story.aspx?guid=%7B6909CE04%2D95A8%2D4E09%2DB0ED%2D420D9D8DCFC8%7D&amp;siteid=yhoof</link><description>Shares of Incyte stand out in pre-holiday trading, rallying on a drug-development deal reached with Novartis.</description><guid isPermaLink="false">yahoo_finance/246196332</guid><pubDate>Wed, 25 Nov 2009 19:02:00 Etc/GMT</pubDate></item><item><title>Tiny Incyte Gets Boost From Novartis Deal (at Minyanville.com)</title><link>http://us.rd.yahoo.com/finance/external/minyanville/rss/SIG=14lqg0h1p/*http%3A//www.minyanville.com/articles/pharmaceutical-novartis-merck-pfizer-incyte-janus-kinase-pharma-pharmaceutical-drugs/index/a/25638/from/yahoo</link><description>The giant Swiss pharmaceutical company continues it slow and steady expansion.</description><guid isPermaLink="false">yahoo_finance/1613683761</guid><pubDate>Wed, 25 Nov 2009 17:45:00 Etc/GMT</pubDate></item></channel></rss><!-- c13.finance.sp2.yahoo.com compressed/chunked Wed Dec 16 17:02:33 PST 2009 -->
